Back to Search
Start Over
Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
- Source :
-
PLoS ONE . 12/12/2024, Vol. 19 Issue 12, p1-1. 1p. - Publication Year :
- 2024
- Subjects :
- *PANCREATIC cancer
*METASTASIS
*OLAPARIB
*ORTHOGRAPHY & spelling
Subjects
Details
- Language :
- English
- ISSN :
- 19326203
- Volume :
- 19
- Issue :
- 12
- Database :
- Academic Search Index
- Journal :
- PLoS ONE
- Publication Type :
- Academic Journal
- Accession number :
- 181620013
- Full Text :
- https://doi.org/10.1371/journal.pone.0315976